Pennsylvania 2017-2018 Regular Session Status: Passed Senate Bipartisan · 5 R · 1 D cosponsors

SB 922 — An Act amending Titles 35 (Health and Safety), 42 (Judiciary and Judicial Procedure) and 61 (Prisons and Parole) of the Pennsylvania Consolidated Statutes, establishing the Nonnarcotic Medication Substance Use Disorder Treatment Program; in organization and jurisdiction of courts of common pleas, providing for court assessments for substance use disorder treatment; in other criminal provisions, further providing for supervisory relationship to offenders; and, in Pennsylvania Board of Probation and Parole, further providing for supervisory relationship to offenders.

Last action — Referred to JUDICIARY

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 2017-2018 Regular Session. It reached “Passed Senate” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.

Bill Text

What changed in the latest version

257 added · 290 removed

Plain-language change summary

The recent amendments to Bill SB 922 changed the terminology from "substance use disorder" to "substance abuse" throughout the text, and clarified that eligible providers must be capable of administering FDA-approved nonnarcotic medications for treatment. This shift emphasizes a more precise medical approach to treatment and ensures that only licensed organizations handle assessments and treatment plans, which could improve the quality and consistency of care for individuals struggling with addiction. These changes matter because they could lead to better outcomes for those seeking help by promoting evidence-based treatment practices.

→
Previous
Latest
PRIOR PRINTER'S NOS.
PRINTER'S NO.
1236, 1597 PRINTER'S NO.
1236 THE GENERAL ASSEMBLY OF PENNSYLVANIA SENATE BILL Session of No.
1762 THE GENERAL ASSEMBLY OF PENNSYLVANIA SENATE BILL Session of No.
922 2017 INTRODUCED BY LANGERHOLC, SCARNATI, RAFFERTY, WHITE, BREWSTER, BLAKE, YUDICHAK, MARTIN AND STEFANO, OCTOBER 11, 2017ENLEAF, REFERRED TO JUDICIARY, OCTOBER 11, 2017 AN ACT Amending Titles 35 (Health and Safety), 42 (Judiciary and Judicial Procedure) and 61 (Prisons and Parole) of the Pennsylvania Consolidated Statutes, establishing the Nonnarcotic Medication Substance Abuse Treatment Program;
922 2017 INTRODUCED BY LANGERHOLC, SCARNATI, RAFFERTY, WHITE, BREWSTER, BLAKE, YUDICHAK, MARTIN AND STEFANO, OCTOBER 11, 2017ENLEAF, AS AMENDED ON SECOND CONSIDERATION, MAY 21, 2018 AN ACT Amending Titles 35 (Health and Safety), 42 (Judiciary and Judicial Procedure) and 61 (Prisons and Parole) of the Pennsylvania Consolidated Statutes, establishing the Nonnarcotic Medication Substance Use Disorder Treatment Program;
in organization and jurisdiction of courts of common pleas, providing for court assessments for substance abuse treatment;
in organization and jurisdiction of courts of common pleas, providing for court assessments for substance use disorder treatment;
and, in for supervisory relationship to offenders., further providing The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows:
and, in State to offenders., further providing for supervisory relationship The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows:
CHAPTER 52B NONNARCOTIC MEDICATION SUBSTANCE USE DISORDER TREATMENT PROGRAM Sec.
CHAPTER 52B NONNARCOTIC MEDICATION SUBSTANCE ABUSE TREATMENT PROGRAM Sec.
"Eligible provider." An organization or entity licensed by the Commonwealth capable of:
"Eligible provider." An organization or entity capable of:
(1) assessing an offender to determine if the offender is a candidate to whom medication that prevents a relapse to drug and alcohol dependence should be administered;
(1) assessing a defendant to determine if the defendant is a candidate to whom medication that prevents a relapse to drug and alcohol dependence should be administered;
and (3) administering an FDA-approved nonnarcotic medication indicated for use in treating a substance use disorder.
and (3) administering long-acting nonnarcotic, nonaddictive medication.
"Nonnarcotic medication assisted substance use disorder treatment." A substance use disorder treatment that includes the use of an FDA-approved nonnarcotic medication indicated for use in treating a substance use disorder, as well as counseling and other substance use disorder treatment measures as deemed clinically appropriate by an eligible provider.
"Nonnarcotic medication assisted substance abuse treatment." A substance abuse treatment that includes the use of long-acting nonnarcotic, nonaddictive medication, as well as counseling and other substance abuse treatment measures as deemed clinically appropriate by a provider.
"Program." The Nonnarcotic Medication Substance Use Disorder Treatment Program established under this chapter.
"Program." The Nonnarcotic Medication Substance Abuse Treatment Program established under this chapter.
"Single county authority." An agency designated by the Department of Health under the act of April 14, 1972 (P.L.221, No.63), known as the Pennsylvania Drug and Alcohol Abuse Control Act, to plan and coordinate drug and alcohol prevention, 20170SB0922PN1762 - 2 - intervention and treatment services for a geographic area, which may consist of one or more counties.
"Single county authority." An agency designated by the Department of Health pursuant to the act of April 14, 1972 (P.L.221, No.63), known as the Pennsylvania Drug and Alcohol Abuse Control Act, to plan and coordinate drug and alcohol prevention, intervention and treatment services for a geographic area, which may consist of one or more counties.
§ 52B02.
20170SB0922PN1236 - 2 - § 52B02.
The Nonnarcotic Medication Substance Use Disorder Treatment Program is established within the department to increase opportunities for single county authorities to provide comprehensive substance use disorder treatment to offenders as may be clinically appropriate through the awarding of grants.
The Nonnarcotic Medication Substance Abuse Treatment Program is established within the department to increase opportunities for single county authorities to provide long-acting nonnarcotic, nonaddictive medication combined with comprehensive substance abuse treatment to defendants as may be clinically appropriate through the awarding of grants.
To the extent that grant money is available, a single county authority may contract with an eligible provider to make available nonnarcotic medication assisted substance use disorder treatment to any offender upon whom a court imposes a sentence of confinement, intermediate punishment, an alternative sentence, probation, Accelerated Rehabilitative Disposition or a fine.
To the extent grant money is available, a single county authority may contract with an eligible provider to make available nonnarcotic medication assisted substance abuse treatment to any defendant upon whom a court imposes a sentence of confinement, intermediate punishment, an alternative sentence, probation, Accelerated Rehabilitative Disposition or a fine.
(2) Enter into a contract with one or more eligible providers as required under section 52B04 (relating to use of grant funding).
(2) Enter into a memorandum of understanding with one or more eligible providers as required under section 52B04 (relating to use of grant funding).
(a) General rule.--Except as provided for in subsection (b), a single county authority awarded a grant under the program shall contract with an eligible provider that shall:
A single county authority awarded a grant under the program shall contract with an eligible provider that shall:
(1) Assess each offender to determine if the offender is 20170SB0922PN1762 - 3 - a candidate to be administered medication that prevents relapse to substance use dependence.
(1) Assess each defendant to determine if the defendant is a candidate to be administered medication that prevents relapse to drug dependence or alcohol dependence, or both.
(2) Create an individualized program for each offender identified under paragraph (1).
(2) Create an individualized program for each defendant 20170SB0922PN1236 - 3 - identified under paragraph (1).
(3) Provide access to and administer nonnarcotic medication assisted substance use disorder treatment when clinically appropriate.
(3) Provide access to and administer nonnarcotic medication assisted treatment when clinically appropriate.
(4) If determined to not be a candidate for nonnarcotic medication assisted substance use disorder treatment, provide recommendations to the single county authority as to what type, if any, of medication assisted treatment may be necessary or helpful to the offender and may make a referral to another medication assisted treatment facility that can provide the appropriate treatment.
(4) Provide clinically appropriate inpatient or outpatient services determined necessary to support each individual's treatment plan.
(5) Provide clinically appropriate inpatient or outpatient services determined necessary to support each individual's treatment plan.
(5) Establish a plan and timetable to collect and disseminate information to the department relating to recidivism, deterrence and overall effectiveness of the program.
(6) Establish a plan and timetable to collect and disseminate the identified DE-IDENTIFIED information to the <-- department relating to recidivism, deterrence, relapses and <-- overall effectiveness of the program.
(b) Exception.--If a single county authority is approved by the department as meeting all of the requirements under subsection (a), the single county authority shall be exempt from the requirement to contract with an eligible provider.
(2) Establish criteria for eligible single county 20170SB0922PN1762 - 4 - authorities applying for grant funding under the program.
(2) Establish criteria for eligible single county authorities applying for grant funding under the program.
(3) Create a form available to eligible providers to be used to confirm that an offender is eligible for and enrolled in the program.
(3) Create a form available to providers to be used to confirm that an offender is eligible for and enrolled in the program.
(4) Promulgate rules and regulations as necessary to implement this chapter.
(4) Promulgate rules and regulations necessary to implement this chapter.
(5) In coordination with the Department of Corrections, <-- issue ISSUE a report to the General Assembly relating to <-- recidivism, deterrence, relapses and overall effectiveness of <-- the program no later than one year from the effective date of this section and no later than December 15 of each calendar year thereafter.
(5) Seek input from the Supreme Court regarding the powers and duties enumerated under this chapter.
(b) Limits on grant awards.--Grant awards shall be at the discretion of the department and shall be limited to amounts annually appropriated to the department for the program.
(6) Issue a report to the General Assembly relating to recidivism, deterrence and overall effectiveness of the program no later than one year from the effective date of this section and no later than December 15th of every calendar year thereafter.
(c) Statewide substance use disorder treatment assessment coordinator.--To the extent that money is available, the department may appoint a Statewide substance use disorder treatment assessment coordinator.
(b) Limits on grant awards.--Grant awards shall be at the discretion of the department and shall be limited to amounts 20170SB0922PN1236 - 4 - annually appropriated to the department for the program.
(c) Statewide substance abuse treatment assessment coordinator.--To the extent that money is available, the department may appoint a Statewide substance abuse treatment assessment coordinator.
(1) Encourage and assist in the establishment of substance use disorder treatment assessments in each judicial district.
(1) Encourage and assist in the establishment of substance abuse treatment assessments in each judicial district.
(2) Identify sources of funding for substance use disorder treatment assessments, including the availability of grants.
(2) Identify sources of funding for substance abuse treatment assessments, including the availability of grants.
(4) Develop model guidelines for the administration of substance use disorder treatment assessments.
(4) Develop model guidelines for the administration of substance abuse treatment assessments.
(5) Establish procedures for monitoring substance use 20170SB0922PN1762 - 5 - disorder treatment assessments and for evaluating the effectiveness of substance use disorder treatment assessments.
(5) Establish procedures for monitoring substance abuse treatment assessments and for evaluating the effectiveness of substance abuse treatment assessments.
(d) Advisory committee.--The department may establish, from available money, an interdisciplinary and interbranch advisory committee to advise and assist the Statewide substance use disorder treatment assessment coordinator in monitoring and administrating substance use disorder treatment assessments Statewide.
(d) Advisory committee.--The department may establish, from available money, an interdisciplinary and interbranch advisory committee to advise and assist the Statewide substance abuse treatment assessment coordinator in monitoring and administrating substance abuse treatment assessments Statewide.
Court assessments for substance use disorder treatment.
Court assessments for substance abuse treatment.
(a) Establishment.--Except as provided in subsection (b), <-- the THE court of common pleas of a judicial district, a problem- <-- solving court and the Municipal Court of Philadelphia may order an offender charged with a drug-related offense upon whom a court imposes a sentence of confinement, intermediate punishment, an alternative sentence, probation, Accelerated Rehabilitative Disposition or a fine to be assessed by an eligible provider to determine whether the use of a nonnarcotic medication assisted substance use disorder treatment program may be clinically appropriate for the offender.
(a) Establishment.--Except as provided in subsection (b), the court of common pleas of a judicial district, a problem- solving court and the Municipal Court of Philadelphia may order a defendant charged with a drug-related offense upon whom a court imposes a sentence of confinement, intermediate punishment, an alternative sentence, probation, Accelerated 20170SB0922PN1236 - 5 - Rehabilitative Disposition or a fine to be assessed by an eligible provider to determine whether the use of a nonnarcotic medication assisted substance abuse treatment program may be clinically appropriate for the defendant.
The court may adopt local rules for substance use disorder treatment assessments.
The court may adopt local rules for substance abuse treatment assessments.
Show all 78 changed rows (38 more)
Previous
Latest
The local rules may not be inconsistent with this section or any rules established by the General Assembly or the Supreme Court.
The local rules may not be inconsistent with this section or any rules established by the Supreme Court.
(b) Noneligibility.--The following offenders are not <-- eligible for the program under subsection (a).
(b) Noneligibility.--The following defendants are not eligible for the program under subsection (a).
An offender who:
A defendant who:
(2) Has been subject to a sentence which included an enhancement for the use of a deadly weapon as defined under law or the sentencing guidelines promulgated by the 20170SB0922PN1762 - 6 - Pennsylvania Commission on Sentencing.
(2) Has been subject to a sentence which included an enhancement for the use of a deadly weapon as defined under law or the sentencing guidelines promulgated by the Pennsylvania Commission on Sentencing.
(3) Has been found guilty or was convicted of an offense involving a deadly weapon, an offense under 18 Pa.C.S.
(3) Has been found guilty of or was convicted of an offense involving a deadly weapon, an offense under 18 Pa.C.S.
(4) Has been found guilty or previously convicted of or adjudicated delinquent for committing or attempting or conspiring to commit a personal injury crime as defined under section 103 of the act of November 24, 1998 (P.L.882, No.111), known as the Crime Victims Act, except for an offense under 18 Pa.C.S.
(4) Has been found guilty of or previously convicted of or adjudicated delinquent for or an attempt or conspiracy to commit a personal injury crime as defined under section 103 of the act of November 24, 1998 (P.L.882, No.111), known as the Crime Victims Act, except for an offense under 18 Pa.C.S.
§ 2701 (relating to simple assault) when the offense is a misdemeanor of the third degree, or an equivalent offense under the laws of the United States or one of its territories or possessions, another state, the District of Columbia, the Commonwealth of Puerto Rico or a foreign nation.
§ 2701 (relating to simple assault) when the offense is a misdemeanor of the third degree, or an equivalent offense under the laws of the United States or one of its territories or possessions, another state, the District of Columbia, the 20170SB0922PN1236 - 6 - Commonwealth of Puerto Rico or a foreign nation.
(iv) Any offense for which registration is required 20170SB0922PN1762 - 7 - under 42 Pa.C.S.
(iv) Received a criminal sentence pursuant to 42 Pa.C.S.
Ch.
§ 9712.1 (relating to sentences for certain drug offenses committed with firearms).
97 Subch.
H (relating to registration of sexual offenders).
I (relating to continued registration of sexual offenders).
H (relating to registration of sexual offenders).
(6) Received a criminal sentence under 42 Pa.C.S.
(6) Is awaiting trial or sentencing for additional criminal charges, if a conviction or sentence on the additional charges would cause the defendant to become ineligible under this subsection.
§ 9712.1 (relating to sentences for certain drug offenses committed with firearms) or has been found guilty, previously convicted or adjudicated delinquent for violating an equivalent offense under the laws of the United States or one of its territories or possessions, another state, the District of Columbia, the Commonwealth of Puerto Rico or a foreign nation.
(c) Failure to participate.--If treatment is determined clinically appropriate by an eligible provider, a defendant's failure to participate in a recommended treatment plan as determined by the court-ordered assessment may be considered by the court to be a probation or parole violation and treated as such under appropriate State or local court rules.
(7) Is awaiting trial or sentencing for additional criminal charges, if a conviction or sentence on the additional charges would cause the offender to become ineligible under this subsection.
(d) Definitions.--The following words and phrases when used in this section shall have the meanings given to them in this section unless the context clearly indicates otherwise:
(c) (B) Failure to participate.--If treatment is determined <-- clinically appropriate by an eligible provider, an offender's failure to participate in a recommended treatment plan as determined by the court-ordered assessment may be considered by the court to be a probation or parole violation and treated as such under appropriate State or local court rules.
20170SB0922PN1236 - 7 - "Drug-related offense." Except for the offenses listed under subsection (b), a criminal offense which the court determines was motivated by the defendant's consumption of or addiction to alcohol or a controlled substance, counterfeit, designer drug, drug, immediate precursor or marihuana, as those terms are defined in the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act.
(d) (C) Definitions.--The following words and phrases when <-- used in this section shall have the meanings given to them in this subsection unless the context clearly indicates otherwise:
"Eligible provider." An organization or entity capable of:
"Drug-related offense." Except for the offenses listed under <-- subsection (b), a A criminal offense which the court determines <-- was motivated by the offender's consumption of or addiction to alcohol or a controlled substance, counterfeit, designer drug, 20170SB0922PN1762 - 8 - drug, immediate precursor or marihuana, as those terms are defined in the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act.
(1) assessing a defendant to determine if the defendant is a candidate to whom medication that prevents a relapse to drug and alcohol dependence should be administered;
"Eligible provider." An organization or entity LICENSED BY <-- THE COMMONWEALTH capable of:
(1) assessing an offender to determine if the offender is a candidate to whom medication that prevents a relapse to drug and alcohol dependence should be administered;
and (3) administering an FDA-approved nonnarcotic medication indicated for use in treating a substance use disorder.
and (3) administering long-acting nonnarcotic, nonaddictive medication.
"Nonnarcotic medication assisted substance use disorder treatment." A substance use disorder treatment that includes the use of an FDA-approved nonnarcotic medication indicated for use in treating a substance use disorder as well as counseling and other substance use disorder treatment measures as deemed clinically appropriate by an eligible provider.
"Nonnarcotic medication assisted substance abuse treatment." A substance abuse treatment that includes the use of long-acting nonnarcotic, nonaddictive medication as well as counseling and other substance abuse treatment measures as deemed clinically appropriate by a provider.
* * * (e.2) Recommendation of offenders for nonnarcotic medication assisted substance use disorder treatment.-- (1) An officer may recommend that an offender under their supervision be assessed by an eligible provider to determine whether the use of the program may be clinically appropriate for the offender as described in section 918 (relating to court assessments for substance use disorder treatment).
* * * (e.2) Recommendation of offenders for nonnarcotic medication assisted substance abuse treatment.-- (1) An officer may recommend that an offender under their supervision be assessed by an eligible provider to determine whether the use of the program may be clinically appropriate for the offender as described in section 918 (relating to court assessments for substance abuse 20170SB0922PN1236 - 8 - treatment).
(2) As used in this subsection, the following words and 20170SB0922PN1762 - 9 - phrases shall have the meanings given to them in this paragraph:
(2) As used in this subsection, the following words and phrases shall have the meanings given to them in this paragraph:
"Eligible provider." An organization or entity LICENSED <-- BY THE COMMONWEALTH capable of:
"Eligible provider." An organization or entity capable of:
(i) assessing an offender to determine if the offender is a candidate to whom medication that prevents a relapse to drug and alcohol dependence should be administered;
(i) assessing a defendant to determine if the defendant is a candidate to whom medication that prevents a relapse to drug and alcohol dependence should be administered;
and (iii) administering an FDA-approved nonnarcotic medication indicated for use in treating a substance use disorder.
and (iii) administering long-acting nonnarcotic, nonaddictive medication.
"Program." The Nonnarcotic Medication Substance Use Disorder Treatment Program established under 35 Pa.C.S.
"Program." The Nonnarcotic Medication Substance Abuse Treatment Program established under 35 Pa.C.S.
52B (relating to Nonnarcotic Medication Substance Use Disorder Treatment Program).
52B (relating to Nonnarcotic Medication Substance Abuse Treatment Program).
* * * (e.1) Recommendation of offenders for nonnarcotic medication assisted substance use disorder treatment.-- (1) An agent may recommend that an offender under their supervision be assessed by an eligible provider to determine whether the use of the program may be clinically appropriate for the offender as described in 42 Pa.C.S.
* * * (e.1) Recommendation of offenders for nonnarcotic medication assisted substance abuse treatment.-- (1) An agent may recommend that an offender under their supervision be assessed by an eligible provider to determine whether the use of the program may be clinically appropriate for the offender as described in 42 Pa.C.S.
§ 918 (relating to court assessments for substance use disorder treatment).
§ 918 (relating to court assessments for substance abuse treatment).
(2) As used in this subsection, the following words and phrases shall have the meanings given to them in this 20170SB0922PN1762 - 10 - paragraph:
(2) As used in this subsection, the following words and 20170SB0922PN1236 - 9 - phrases shall have the meanings given to them in this paragraph:
"Eligible provider." An organization or entity LICENSED <-- BY THE COMMONWEALTH capable of:
"Eligible provider." An organization or entity capable of:
(i) assessing an offender to determine if the offender is a candidate to whom medication that prevents a relapse to drug and alcohol dependence should be administered;
(i) assessing a defendant to determine if the defendant is a candidate to whom medication that prevents a relapse to drug and alcohol dependence should be administered;
and (iii) administering an FDA-approved nonnarcotic medication indicated for use in treating a substance use disorder.
and (iii) administering long-acting nonnarcotic, nonaddictive medication.
"Program." The Nonnarcotic Medication Substance Use Disorder Treatment Program established under 35 Pa.C.S.
"Program." The Nonnarcotic Medication Substance Abuse Treatment Program established under 35 Pa.C.S.
52B (relating to Nonnarcotic Medication Substance Use Disorder Treatment Program).
52B (relating to Nonnarcotic Medication Substance Abuse Treatment Program).
20170SB0922PN1762 - 11 -
20170SB0922PN1236 - 10 -
⬇ Download PDF
View plain text versions (3)

Action History

  1. Referred to JUDICIARY

  2. Third consideration and final passage

  3. Re-reported as committed

  4. Re-referred to APPROPRIATIONS

  5. PN 1762 Second consideration, with amendments

  6. First consideration

  7. PN 1597 Reported as amended

  8. PN 1236 Referred to JUDICIARY

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 15 co-sponsors · 237 not signed on

Sponsors (1)

Co-sponsors (15)

Not signed on (237)

237 members have not signed on to this bill.

Show all 237 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Votes

FINAL PASSAGE

Passed 49 Yea · 0 Nay
Party YeaNayPresentNot Voting
Unaffiliated 28000
Republican 13000
Democratic 8000
Total 49000
% of votes cast 100%0%0%0%
How each member voted (49)
Member Party Vote
ALLOWAY — Yea
AUMENT — Yea
BLAKE — Yea
BREWSTER — Yea
BROWNE — Yea
CORMAN — Yea
DINNIMAN — Yea
DISANTO — Yea
EICHELBERGER — Yea
FARNESE — Yea
FOLMER — Yea
GORDNER — Yea
GREENLEAF — Yea
KILLION — Yea
LEACH — Yea
MCGARRIGLE — Yea
MCILHINNEY — Yea
MENSCH — Yea
RAFFERTY — Yea
REGAN — Yea
RESCHENTHALER — Yea
SABATINA — Yea
SCARNATI — Yea
SCAVELLO — Yea
VULAKOVICH — Yea
WARD — Yea
WILLIAMS — Yea
YUDICHAK — Yea
Art Haywood Democratic Yea
Christine M. Tartaglione Democratic Yea
Jay Costa Democratic Yea
Judith L. Schwank Democratic Yea
Lisa M. Boscola Democratic Yea
Sharif Street Democratic Yea
Vincent J. Hughes Democratic Yea
Wayne D. Fontana Democratic Yea
Camera Bartolotta Republican Yea
Daniel Laughlin Republican Yea
David G. Argall Republican Yea
Elder A. Vogel Republican Yea
Gene Yaw Republican Yea
Kathleen C. Tomlinson Republican Yea
Lisa Baker Republican Yea
Martina A. White Republican Yea
Michele Brooks Republican Yea
Patrick J. Stefano Republican Yea
Scott E. Hutchinson Republican Yea
Scott Martin Republican Yea
Wayne Langerholc Republican Yea

Official roll call →

Committee vote (APPROPRIATIONS): Re-Reported as Committed

Passed 26 Yea · 0 Nay
Party YeaNayPresentNot Voting
Republican 6000
Unaffiliated 14000
Democratic 6000
Total 26000
% of votes cast 100%0%0%0%
How each member voted (26)
Member Party Vote
BLAKE — Yea
BREWSTER — Yea
EICHELBERGER — Yea
GREENLEAF — Yea
KILLION — Yea
LEACH — Yea
MENSCH — Yea
SCAVELLO — Yea
VULAKOVICH — Yea
WAGNER — Yea
WARD — Yea
BROWNE — Yea
CORMAN — Yea
SCARNATI — Yea
Art Haywood Democratic Yea
Christine M. Tartaglione Democratic Yea
Jay Costa Democratic Yea
Judith L. Schwank Democratic Yea
Sharif Street Democratic Yea
Vincent J. Hughes Democratic Yea
David G. Argall Republican Yea
Elder A. Vogel Republican Yea
Gene Yaw Republican Yea
Lisa Baker Republican Yea
Scott Martin Republican Yea
Wayne Langerholc Republican Yea

Official roll call →

Committee vote (JUDICIARY): Reported as Amended

Passed 13 Yea · 0 Nay · 2 Other
Party YeaNayPresentNot Voting
Unaffiliated 10001
Democratic 1001
Republican 2000
Total 13002
% of votes cast 87%0%0%13%
How each member voted (15)
Member Party Vote
ALLOWAY — Yea
EICHELBERGER — Yea
FARNESE — Yea
GORDNER — Yea
RAFFERTY — Yea
RESCHENTHALER — Yea
SABATINA — Yea
VULAKOVICH — Yea
GREENLEAF — Yea
SCARNATI — Yea
LEACH — Not Voting
Art Haywood Democratic Not Voting
Lisa M. Boscola Democratic Yea
Gene Yaw Republican Yea
Wayne Langerholc Republican Yea

Official roll call →

Subjects

public-safety healthcare labor
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors SB 922?
SB 922 is sponsored by Camera Bartolotta (Republican), Brewster, Scott Martin (Republican), White, Ward, Blake, Greenleaf, Wayne Langerholc (Republican), Mensch, Rafferty, Patrick J. Stefano (Republican), Vulakovich, Gene Yaw (Republican), Scarnati, Yudichak, and Jay Costa (Democratic).
What is the current status of SB 922?
This bill died with 2017-2018 Regular Session. It reached “Passed Senate” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track SB 922?
Track SB 922 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 922

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of SB 922

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →